featured
There Is No Evidence to Abandon RAS Blockers During the COVID-19 Pandemic
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Hypertension
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers
Hypertension 2020 Mar 25;[EPub Ahead of Print], AHJ Danser, M Epstein, D BatlleFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.